Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now X
Company Description (as filed with the SEC)
We are a biopharmaceutical company focused on the development of monoclonal antibody therapeutics for diseases that represent a significant burden to society and to patients and their families. Using our proprietary and patented Humaneered® antibody technology, we have produced a portfolio of firstinclass, antibodies to treat serious medical conditions. Historically, our clinical focus had included both respiratory diseases and cancer, however as a result of the recent termination of our respiratory programs, our clinical development efforts going forward will be focused solely in oncology, including both hematologic malignancies as well as potentially solid tumors. By focusing on diseasespecific targets and patient selection criteria in developing our drugs, we aim to provide patients with medicines that are safe and effective and offer innovative approaches compared to current treatments. ... More ...
Where does KBIO fit in the risk graph?
|Annual EPS Est:||$-9.2|
|Quarterly EPS Est:||-1.45|